Durvalumab vs Lansoprazole

## Durvalumab vs Lansoprazole: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Lansoprazole**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Lansoprazole**: Proton pump inhibitor.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Lansoprazole — 1.5 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Lansoprazole — C16H14F3N3O2S.

**Molecular Weight**: Durvalumab — N/A; Lansoprazole — 369.3620 g/mol.

**Type**: Durvalumab — Antibody; Lansoprazole — Small molecule.